Quantcast
Last updated on April 21, 2014 at 8:55 EDT

Latest Systemic scleroderma Stories

2009-10-22 13:50:00

Honoring Congresswoman Linda T. Sanchez (CA) and Actress Kellie Martin Gala to raise funds for the Scleroderma Foundation, Southern California Chapter LOS ANGELES, Oct. 22 /PRNewswire-USNewswire/ -- The 13th Annual "Key to a Cure" Gala takes place Saturday, November 7, at the Manhattan Beach Marriott. Proceeds from the event will benefit the Scleroderma Foundation, Southern California Chapter. (Photo: http://www.newscom.com/cgi-bin/prnh/20091022/DC97406) California Congresswoman...

2009-10-18 08:38:21

Investigators have identified a drug that is currently approved to treat certain types of cancer, Gleevec, that could provide the first treatment for scleroderma, a chronic connective tissue disease for which a treatment has remained elusive. The news will be presented at the annual meeting of the American College of Rheumatology on October 18 in Philadelphia. "There has never been a drug that has been shown to be effective for this condition. I think there is a very good chance of Gleevec...

2009-10-15 13:08:00

GAITHERSBURG, Md., Oct. 15 /PRNewswire/ -- MedImmune today announced that researchers will present data on several inflammatory disease programs at the annual meeting of the American College of Rheumatology, from October 17 to 21, 2009 at the Pennsylvania Convention Center in Philadelphia, Pennsylvania. "Through our research into novel disease pathways involved in autoimmune disorders, we continue to fulfill our mission of using scientific excellence to deliver life-changing medicines...

2009-09-19 10:13:00

LOS ANGELES, Sept. 19 /PRNewswire-USNewswire/ -- The 1st Annual "Fight for Lexi" Charity Golf Tournament takes place on Monday, September 21, at the Dove Canyon County Club. Proceeds from the event will benefit the Scleroderma Foundation/ Southern California Chapter. The event kicks off with a shotgun start at 10:30 a.m., and will be followed by a silent auction and awards dinner. Noted comedian Carlos Mencia will perform a brief comic set at the Awards Dinner at 5:30 p.m. The event is...

2009-08-04 11:37:00

DANVERS, Mass., Aug. 4 /PRNewswire-USNewswire/ -- The Scleroderma Foundation applauds Senator Kirsten Gillibrand (D-NY) for introducing S. 1545, the "Scleroderma Research and Awareness Act" in the United States Senate. This important legislation, co-sponsored by Senator Charles Schumer (D-NY), gives hope to the estimated 300,000 Americans and their families living with this devastating disease. Scleroderma is a chronic and disabling connective tissue disorder resulting from an...

2009-07-16 08:00:00

DANVERS, Mass., July 16 /PRNewswire/ -- The Scleroderma Foundation, the nation's leading non-profit supporter of scleroderma research, is holding the Gateway to Hope 2009 National Patient Education Conference July 17-19, 2009 in St. Louis, Missouri. Scleroderma, an autoimmune disease without a known cure, affects an estimated 300,000 people in the U.S., making it as common as multiple sclerosis. Scleroderma causes collagen to build up in the tissues of the skin and in internal organs,...

2009-05-15 10:22:00

DANVERS, Mass., May 15 /PRNewswire/ -- The Scleroderma Foundation applauds Rep. Lois Capps (D-CA) and Rep. Vern Ehlers (R-MI) for introducing H.R. 2408, the "Scleroderma Research and Awareness Act" in the House of Representatives today. This bipartisan legislation gives hope to the estimated 300,000 Americans and their families living with this devastating disease. Scleroderma is a chronic and disabling connective tissue disorder resulting from an overproduction of collagen. The word...

2008-10-24 09:00:06

DANVERS, Mass., Oct. 24 /PRNewswire/ -- The Scleroderma Foundation, in conjunction with leading rheumatologists and pulmonary hypertension specialists, today announced the launch of the ECHO educational campaign to raise awareness of the increased risk of developing pulmonary arterial hypertension (PAH) among scleroderma patients, and to encourage healthcare professionals to conduct annual echocardiograms to ensure that PAH is diagnosed and treated early. PAH is a rare, life-threatening...

2008-07-01 09:00:12

arGentis Pharmaceuticals, LLC announced today that it has filed a patent application for Nucleic Acid Sequences highly associated with the inability of oral immune tolerance to be induced in some systemic sclerosis (SSc) patients. As explained in the patent application, the identified sequences predict which patients can respond to ARG201, an immunotherapy that induces oral immune tolerance in patients with Late Phase diffuse cutaneous systemic sclerosis. Results from patient DNA samples...

2008-06-30 12:02:16

arGentis Pharmaceuticals, LLC announced today that the Phase II results using highly purified type 1 bovine collagen orally (now known as ARG201) in the treatment of diffuse cutaneous systemic sclerosis (scleroderma - SSc) have been published in the June issue of Arthritis & Rheumatism, a major peer-reviewed rheumatology research journal. Systemic sclerosis is an autoimmune disease causing widespread fibrosis of the skin and internal organs. ARG201 is an immunotherapy that induces low...